PeptideLabs Logo
PeptideLabs
质量文档记录
Back to all 64 profiles
Approved medicine特定用途获批

Community protocol · Thymosin Alpha-1

Thymosin Alpha-1: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: Thymalfasin · Tα1 · Zadaxin

Sources checked: 27 August 2026

重要安全与责任声明

本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

Thymosin Alpha-1

用于免疫调节研究，并在部分国家获批特定用途，但并未普遍获得 FDA 或 EMA 批准。

Approved uses exist, but dose, formulation, device and monitoring are product- and indication-specific. A community table cannot replace the prescribing information or a prescription.

Amounts, timing and cycles

Approved medicine

Approved uses exist, but dose, formulation, device and monitoring are product- and indication-specific. A community table cannot replace the prescribing information or a prescription.

Amount status

Only the prescribing information for the exact approved product applies; brands, concentrations and indications are not interchangeable.

Profile evidence level: clinical.

Timing

Intervals, time of day and missed-dose handling depend on the product and indication.

No individual recommendation.

Cycle/duration

Approved medicines are clinician-managed treatment, not freely designed community cycles.

No individual recommendation.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

复配与 U-100 换算

No generic calculator

For approved finished products, only the relevant prescribing information, original concentration and intended delivery system apply. Prefilled pens, syringes or product-specific vials must not be converted with a generic U-100 table.

For approved finished products, only the relevant prescribing information, original concentration and intended delivery system apply. Prefilled pens, syringes or product-specific vials must not be converted with a generic U-100 table.

Mechanism and research questions

Synthetic version of an endogenous immune-modulating peptide

Thymosin Alpha-1 is classified as “Synthetic version of an endogenous immune-modulating peptide”. 用于免疫调节研究，并在部分国家获批特定用途，但并未普遍获得 FDA 或 EMA 批准。 This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

免疫调节肽

这项研究考察某肽如何调节免疫细胞活性,类似于增强或抑制免疫反应的旋钮。研究中测量免疫细胞计数和炎症标志物。

02

抗菌宿主防御

研究人员研究天然存在的防御肽如何攻击细菌并影响炎症信号,类似于皮肤和黏膜的第一道防线。在实验室中测量细菌生长和免疫标志物。

03

胸腺来源混合物

这涉及最初从胸腺组织中鉴定出、与免疫成熟相关的肽混合物,类似于一系列相关信号的集合,而非单一确定的药物。研究更多针对单个成分,而非整个混合物。

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

综合健康论坛

人们在此交流使用各类产品后情绪、睡眠和整体感受等更宽泛的健康印象,通常没有结构化的记录。这类笼统印象无法替代有针对性的临床检查。

生物黑客与长寿论坛

用户比较自行组合的肽方案,以期影响衰老过程或能量水平,常常依据血液检测或主观幸福感量表。个人自我实验和营销承诺无法取代对照的长期人体研究。

来源与纯度讨论

人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。

Adverse effects and risk boundaries

  • 调节免疫或抗菌信号可能影响炎症、超敏反应、感染风险及不可预测的免疫反应；给药途径和制剂至关重要。
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

  • 自身免疫病、移植、免疫抑制、活动性感染、癌症和妊娠均需专科评估。
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • 根据适应证，血常规、炎症指标、感染征象、肝肾功能及免疫参数可能相关；不存在通用社区监测方案。
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

临床试验中

尽管该物质在部分国家获批,但尚未获得FDA或EMA的普遍批准。

Published evidence

该物质目前正在结构化的人体临床试验中进行研究,尚未获得普遍批准。

胸腺素α1是一种单一、明确的免疫肽,已在部分国家获批,不同于未标准化的Thymalin制剂。

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

特定用途获批

在至少一个司法辖区作为特定适应证的处方活性成分；本网站不提供该产品。

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Back to all 64 profilesOpen scientific atlas profile